A single-stock leveraged ETF that seeks to deliver twice the daily return of Astera Labs common stock, using swap agreements to build its exposure.

It is designed for short-term traders looking to bet on the near-term direction of Astera Labs shares and is not suited for long-term holding.

The fund is managed by Tradr using an active management approach.

The fund gains 2x daily exposure to Astera Labs through swap agreements and resets its leverage ratio each day at the close. Its non-diversified structure concentrates exposure in a single name: Astera Labs.

• Single-stock 2x leveraged product
• Swap-based structure with daily rebalancing

Assets under management (AUM) stand at $50.6M, with a total expense ratio of 1.30% annually.

Unlike index and sector leveraged ETFs such as TQQQ and SOXL shown alongside it in the table, this product is exposed only to Astera Labs, making the difference in diversification level notable.

Because it amplifies daily moves in the underlying Astera Labs stock by 2x, gains are larger when the trend persists, but when the price whipsaws, the compounding effect tends to erode returns.

Since launch, the fund has attracted inflows from short-term traders looking to take positions in semiconductor-related names, and trading volumes tend to swing sharply with news flow around Astera Labs.

The leveraged exposure for betting on short-term upside in Astera Labs is a strength, but the daily-rebalanced structure carries meaningful volatility decay risk.

The three names shown alongside it in the table — TQQQ, SOXL, and QLD — are index and sector leveraged products tracking the Nasdaq-100, the semiconductor index, and 2x the Nasdaq-100 respectively, and they differ from LABX in that they are diversified across multiple stocks rather than concentrated in one. MUU, a 2x leveraged product on Micron alone, has a similar structure to LABX and is another comparable option, while investors looking to bet on a decline in Astera Labs shares should separately review inverse products.

Points to review before investing in LABX. Because of its leveraged and non-diversified structure, the approach should differ from that used for standard index ETFs, and it is important to plan entry timing and holding period in advance.

If Astera Labs shares experience repeated sharp swings, the daily-rebalanced structure can produce losses larger than those of the underlying. The single-name concentration also makes the fund highly sensitive to events such as earnings announcements.

Positioned as a high-risk product for traders seeking to bet on the short-term direction of Astera Labs, it is recommended for short-term trading purposes rather than long-term investing.

The leveraged exposure for betting on short-term upside in Astera Labs is a strength, but the daily-rebalanced structure carries meaningful volatility decay risk.

The three names shown alongside it in the table — TQQQ, SOXL, and QLD — are index and sector leveraged products tracking the Nasdaq-100, the semiconductor index, and 2x the Nasdaq-100 respectively, and they differ from LABX in that they are diversified across multiple stocks rather than concentrated in one. MUU, a 2x leveraged product on Micron alone, has a similar structure to LABX and is another comparable option, while investors looking to bet on a decline in Astera Labs shares should separately review inverse products.

Points to review before investing in LABX. Because of its leveraged and non-diversified structure, the approach should differ from that used for standard index ETFs, and it is important to plan entry timing and holding period in advance.

If Astera Labs shares experience repeated sharp swings, the daily-rebalanced structure can produce losses larger than those of the underlying. The single-name concentration also makes the fund highly sensitive to events such as earnings announcements.

Positioned as a high-risk product for traders seeking to bet on the short-term direction of Astera Labs, it is recommended for short-term trading purposes rather than long-term investing.